VB

Vsy Biotechnology

www.vsybiotechnology.com link_icon

Company Research Report: VSY Biotechnology GmbH





Company Overview



  • Name: VSY Biotechnology GmbH

  • Mission: No information is available.

  • Founded: No information is available.

  • Founder: No information is available.

  • Key People:

  • Recent appointment: Nagihan ŞENGÜL KARPUZ to the Board of Directors.

  • Headquarters: Esslingerst. 7, 70771 Leinfelden-Echterdingen, Germany.

  • Number of Employees: No information is available.

  • Revenue: No information is available.

  • Core Competency: Known for advancing ophthalmology through innovative intraocular lens (IOL) technologies and materials. They focus on presbyopia correction, cataract treatment, astigmatism correction, and produce orthopedics solutions such as treatments for osteoarthritis.


Products



  • Ophthalmology:

  • IOL Family: Intraocular lenses for various vision corrections including trifocal presbyopia-correcting lenses.

  • Key Products:

  • AcrivaUD: The first and only trifocal presbyopia-correcting (PC-IOL) lens with patented enhancement technologies.

  • Enova®: Available in a C Haptic Model, offering advanced vision correction features.

  • Maestro®: Known as the Sinusoidal IOL, uses Sinusoidal Vision Technology (SVT®).

  • Recent Innovations:

  • 100% Glistening-Free IOL Material: A significant advancement in IOL technology by reducing visual disturbances.


  • Orthopedics:

  • IAI Family: Solutions for treating osteoarthritis with innovative materials and design.


  • Additional Tools:

  • Easy Toric Calculator: A new tool introduced to aid surgeons in toric IOL implantation.

  • Rotaryjet Preloaded Injector System: A patented device aimed at improving surgical efficiency.

  • Cartridge, Injector System, OVD: Essential elements for ophthalmic procedures enhancing user experience and outcomes.


Recent Developments



  • New Products and Features:

  • Introduction of Preloaded Enova® IOL Family: Expanding their offerings in IOL technology.

  • Maestro® Sinusoidal IOL Launch: Incorporates Sinusoidal Vision Technology to aid in optimizing visual outcomes.


  • New Initiatives:

  • VSY Biotechnology Ophthalmology Star Awards (OSA) 2024: Recognizing contributions to ophthalmology. Winners include Suphi Taneri (Germany), Liliana Werner (USA), and Paolo Fogagnolo (Italy).

  • Patent Registrations: Secured patents for various innovations including the Sinusoidal Vision Technology in China.


  • Partnerships:

  • Signed an agreement with WAKAMO, indicative of expanding collaborative efforts.


Conclusion



VSY Biotechnology GmbH is an innovation-driven company focused on advancing ophthalmology and orthopedics through its wide array of specialized products. While specific financial and employee metrics are not available, the company's recent technological advancements and strategic partnerships underscore its leading role in the industry. With headquarters in Germany, VSY Biotechnology continues to revolutionize vision correction, celebrating research contributions globally.


End of the report.